Positron-emission tomography for hepatocellular carcinoma:Current status and future prospects  

作　　者：Ren-Cai Lu Bo She Wen-Tao Gao Yun-Hai Ji Dong-Dong Xu Quan-Shi Wang Shao-Bo Wang 

机构地区：[1]PET-CT Center,the First People’s Hospital of Yunnan Province,Kunming 650032,Yunnan Province,China [2]Nanfang PET Center,Nanfang Hospital,Southern Medical University,Guangzhou 510515,Guangdong Province,China [3]Yunnan Key Laboratory of Primate Biomedical Research,Institute of Primate Translational Medicine,Kunming University of Science and Technology,Kunming 650093,Yunnan Province,China

出　　处：《World Journal of Gastroenterology》2019年第32期4682-4695,共14页世界胃肠病学杂志（英文版）

基　　金：Supported by the National Natural Science Foundation of China,No.81760306;the Basic Research on Application of Joint Special Funding of Science and Technology Department of Yunnan Province-Kunming Medical University,No.2018FE001(-291)

摘　　要：Hepatocellular carcinoma(HCC)is one of the leading causes of cancer mortality worldwide.Various imaging modalities provide important information about HCC for its clinical management.Since positron-emission tomography(PET)or PET-computed tomography was introduced to the oncologic setting,it has played crucial roles in detecting,distinguishing,accurately staging,and evaluating local,residual,and recurrent HCC.PET imaging visualizes tissue metabolic information that is closely associated with treatment.Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis.The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance.The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein.Hepatocellular carcinoma(HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography(PET) or PET-computed tomography was introduced to the oncologic setting, it has played crucial roles in detecting, distinguishing, accurately staging, and evaluating local, residual, and recurrent HCC. PET imaging visualizes tissue metabolic information that is closely associated with treatment. Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis. The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance. The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein.

关 键 词：HEPATOCELLULAR CARCINOMA Positron-emission TOMOGRAPHY Radiotracer Immuno-positron EMISSION TOMOGRAPHY 

分 类 号：R[医药卫生]